Pharmagreen Biotech Inc.
PHBI
$0.0012
$0.00019.09%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 633.30K | -779.10K | -42.50K | -38.00K | -144.90K |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -724.30K | 726.60K | -26.60K | -43.80K | 68.70K |
| Change in Net Operating Assets | 84.10K | 53.50K | 68.50K | 55.30K | 74.20K |
| Cash from Operations | -6.90K | 1.10K | -700.00 | -26.50K | -2.00K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 13.70K | 0.00 | 500.00 | 28.20K | -- |
| Total Debt Repaid | -- | 0.00 | 0.00 | -100.00 | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 13.70K | 0.00 | 500.00 | 28.00K | -- |
| Foreign Exchange rate Adjustments | -6.20K | -1.00K | -200.00 | -1.70K | 1.50K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 600.00 | 0.00 | -300.00 | -200.00 | -500.00 |
